MeSH D051474 - postherpetic neuralgia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Gabapentin | Gabapentin | 2004-10-08 | |||
| Pregabalin | Pregabalin | 2019-07-19 | ||||
| Taro Pharmaceutical | Gabapentin | Gabapentin | 2013-07-03 | |||
| Glenmark Pharmaceuticals | Gabapentin | Gabapentin | 2006-08-18 | |||
| Mylan | Gabapentin | Gabapentin | 2011-02-14 | |||
| Pregabalin | Pregabalin | 2019-09-20 | ||||
| Pregabalin | Pregabalin Mylan | 2015-06-24 | ||||
| Pregabalin | Pregabalin Mylan Pharma | 2015-06-25 | ||||
| Cipla | Gabapentin | Gabapentin | 2009-12-30 | |||
| Pregabalin | Pregabalin | 2019-07-19 | ||||
| Lupin Research | Gabapentin | Gabapentin | 2018-08-24 | |||
| Pregabalin | Pregabalin | 2022-05-03 | ||||
| Sandoz | Gabapentin | Gabapentin | 2006-01-24 | |||
| Pregabalin | Pregabalin Sandoz | 2015-06-19 | ||||
| Pregabalin | Pregabalin Sandoz GmbH | 2015-06-19 | ||||
| Aurobindo Pharma | Gabapentin | Gabapentin | 2008-01-31 | |||
| Pregabalin | Pregabalin | 2023-03-29 | ||||
| Dr Reddys Laboratories | Pregabalin | Pregabalin | 2019-07-19 | |||
| Rising Pharmaceuticals | Pregabalin | Pregabalin | 2019-07-19 | |||
| Gabapentin | Gabapentin | 2017-03-24 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
78%7/9
Phase 2
55%16/29
Phase 3
57%8/14
Approved: 3Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use